Brian DiCarlo
Impact in
-
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 2
- Advanced Breast Cancer Therapies 2
- Oncology 3
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Ravi Patel (4 shared papers)Haijun Wang (1 shared paper)Robert M. Elashoff (1 shared paper)J. Randolph Hecht (1 shared paper)David W. Chan (3 shared papers)Dennis J. Slamon (2 shared papers)William Lawler (2 shared papers)Nicholas P. McAndrew (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)Lung Cancer (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Brian DiCarlo
10 papers receiving 164 citations
Peers
Comparison fields: 5 of 37
- Oncology 92
- Pulmonary and Respiratory Medicine 86
- Gastroenterology 10
- Cancer Research 17
- Genetics 9
Countries citing papers authored by Brian DiCarlo
This map shows the geographic impact of Brian DiCarlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian DiCarlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian DiCarlo more than expected).
Fields of papers citing papers by Brian DiCarlo
This network shows the impact of papers produced by Brian DiCarlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian DiCarlo. The network helps show where Brian DiCarlo may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian DiCarlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 64 | |
| 2 | 2018 | 26 | |
| 3 | 2022 | 21 | |
| 4 | 2015 | 17 | |
| 5 | 2019 | 10 | |
| 6 | 2023 | 9 | |
| 7 | 2015 | 6 | |
| 8 | 2014 | 5 | |
| 9 | 2010 | 4 | |
| 10 | 2014 | 3 | |
| 11 | 2026 | 0 |
About Brian DiCarlo
Brian DiCarlo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Molecular Biology, having authored 11 papers that have together received 165 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Estrogen and related hormone effects (2 papers), Breast Cancer Treatment Studies (2 papers), Prostate Cancer Treatment and Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Cancer, Lipids, and Metabolism (1 paper), Heat shock proteins research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (92 citations), Pulmonary and Respiratory Medicine (86 citations), Gastroenterology (10 citations), Cancer Research (17 citations) and Genetics (9 citations). Brian DiCarlo has collaborated with scholars based in United States and China. Frequent co-authors include Ravi Patel, Haijun Wang, Robert M. Elashoff, J. Randolph Hecht, David W. Chan, Dennis J. Slamon, William Lawler, Nicholas P. McAndrew, Sara A. Hurvitz and Isett Laux. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Lung Cancer, Therapeutic Advances in Medical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.